We investigated the potential role of PB28 and sigma‐2 receptor antagonist 1 in modulating the invasion and migration abilities of renal cancer cells by the transwell invasion assay with Matrigel and the wound healing assay, respectively. Here, TMEM97 is linked to renal carcinoma.